Novavax





Ebit Cambiamento Data
Adma Biologics USD 49.19M 7.26M 2025-09
Agenus USD -13.31M 19.08M 2025-03
AstraZeneca USD 2.97B 4.48B 2025-12
BioCryst Pharmaceuticals USD -4.51M 12.2M 2024-12
Cassava Sciences USD -11.86M 33.53M 2025-09
Geron USD -10.79M 3.1M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
MannKind USD -69.24M 28.19M 2025-12
Merck USD 6.24B 1.32B 2025-12
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Moderna USD -857M 597M 2025-12
Novartis USD 4.48B 343M 2025-09
Novavax USD -134.02M 49.55M 2024-09
Pfizer USD 4.65B 71M 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
TG Therapeutics USD 50.49M 21.13M 2025-12


Novavax - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.